Registered Rwanda · Rwanda FDA

PZ-4

PIMOZIDE BP

Rwanda FDA-HMP-MA-1955 TABLETS 4MG INN generic

What it does

Pimozide is a medication used to treat certain mental health conditions, particularly symptoms associated with schizophrenia and Tourette syndrome.

Commonly used for: schizophrenia, Tourette syndrome

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
Rwanda FDA-HMP-MA-1955
Registration date
17/08/2024
Expiry date
16/08/2029
Status
Registered
Active ingredient
PIMOZIDE BP
Dosage form
TABLETS
Strength
4MG
Pack size
240 Tablets
Therapeutic class
-
Manufacturer / MAH
Agog Pharma
Applicant / LTR
AGOG PHARMA LTD
Country of origin
India
Manufacturer location
33, Gaonraipada Sector 2,The Taluka Ind. co. op. estate, Vasai, Sector 2, Golani Naka, Vasai East, Vasai-Virar, Maharashtra 401208, India

Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:04 · updated 2026-09-17 02:30:43

Drug Interactions

26
Check interactions

Pharmacodynamic Warnings

Pimozide appears in TABLE 8: Drugs that cause hypotension

Pimozide appears in TABLE 9: Drugs that prolong the QT interval

Pimozide appears in TABLE 10: Drugs with antimuscarinic effects

Pimozide appears in TABLE 11: Drugs with CNS depressant effects

Severe (7)

Dopamine Receptor Agonists - decreases effects

Pimozide is predicted to decrease the effects of dopamine receptor agonists. Avoid. Also see TABLE 8 p. 1518 → Also see TABLE 9 p. 1519 → Also see TABLE 10 p. 1519

Severe Theoretical

Pimozide - increases exposure

Antifungals,azoles(fluconazole,isavuconazole,posaconazole) arepredictedtoincreasetheexposuretopimozide.Avoid. rTheoretical →AlsoseeTABLE9p.1519

Severe Theoretical

Pimozide - increases exposure

Grapefruitjuiceincreasestheexposuretopimozide.Avoid. rTheoretical

Severe Theoretical

Pimozide - increases exposure

Clarithromycin is predicted to increase the exposure to pimozide. Avoid. Also see TABLE 9 p. 1519

Severe Study

Pimozide - increases exposure

Erythromycin is predicted to increase the exposure to pimozide. Avoid. Also see TABLE 9 p. 1519

Severe Theoretical

Pimozide - increases exposure

Panobinostat is predicted to increase the exposure to pimozide. Avoid. Theoretical. Also see TABLE 9 p. 1519

Severe Theoretical

Pimozide - increases exposure

Ribociclib (high-dose) is predicted to increase the exposure to pimozide. Avoid. Also see TABLE 9 p. 1519

Severe Theoretical

Moderate (3)

Pimozide - increases exposure

Larotrectinibispredictedtoincreasetheexposuretopimozide. Usewithcautionandadjustdose.nTheoretical 1xidneppA|snoitcaretnI A1 com/codemedicalapps/ cal Applications)

Moderate Theoretical

Pimozide - increases exposure

Palbociclibispredictedtoincreasetheexposuretopimozide. Adjustdose.oTheoretical

Moderate Theoretical

Pimozide - increases exposure

Rucaparib is predicted to increase the exposure to pimozide. Monitor and adjust dose. Pindolol → see beta blockers, non-selective Pioglitazone → see TABLE 14 p. 1520 (antidiabetic drugs)

Moderate Study

Unknown (16)

Antipsychotics - additive effect

Antipsychotics,secondgeneration(clozapine)cancause constipation,ascanantipsychotics,secondgeneration (olanzapine,quetiapine);concurrentusemightincreasethe riskofdevelopingintestinalobstruction.rAnecdo

Unknown Anecdotal

Levodopa - decreases effects

Pimozide decreases the effects of levodopa. Theoretical → Also see TABLE 8 p. 1518

Unknown Theoretical

Pimozide - increases exposure

Dronedaroneispredictedtoincreasetheexposuretopimozide. Avoid.rTheoretical →AlsoseeTABLE9p.1519

Unknown Theoretical

Pimozide - increases exposure

Miconazoleispredictedtoincreasetheexposuretopimozide. Avoid.oTheoretical

Unknown Theoretical

Pimozide - additive effect

Clozapinecancauseconstipation,ascanpimozide;concurrent usemightincreasetheriskofdevelopingintestinal obstruction.rTheoretical →AlsoseeTABLE8p.1518 →Also seeTABLE11p.1519→AlsoseeTABLE10p.1519

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: exact

Disclaimer: This information is sourced from Rwanda Food and Drugs Authority (Rwanda). Always consult a qualified healthcare professional before using any medication.

About this medicine

Pimozide is a medication used to treat certain mental health conditions, particularly symptoms associated with schizophrenia and Tourette syndrome.

What it treats

  • schizophrenia
  • Tourette syndrome

How it works

Pimozide works by helping to balance chemicals in the brain that affect mood and behavior.

Who it's for

This medication is typically prescribed for adults and children with specific mental health disorders.

Drug class

Antipsychotics

Cautions

  • • Be cautious if you are taking medications that lower blood pressure.
  • • Avoid medications that may affect heart rhythm.
  • • Use with care if taking drugs that have strong sedative effects.
  • • Be aware of medications that may cause dry mouth or other antimuscarinic effects.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Pimozide

BNF-referenced

Pimozide is an antipsychotic medication primarily used to treat Tourette's disorder and other severe mental or behavioral disorders. It works by blocking dopamine D2 receptors in the central nervous system, which is believed to be responsible for its effectiveness in suppressing tics and managing psychotic symptoms. Pimozide has a more specific action on dopaminergic pathways, making it a suitable alternative to other neuroleptics such as haloperidol.

Indications

  • Tourette's disorder
  • Severe mental or behavioral disorders
  • Schizophrenia (under expert supervision)
  • Psychoses

Dosage

Children: Refer to BNF for Children for specific dosing guidance.

Adults: Initially 15–30 mg daily in 2 divided doses, adjusted according to response, with larger doses taken under supervision in a hospital setting.

Mechanism of action

Pimozide's ability to suppress motor and phonic tics in Tourette's disorder is primarily due to its dopaminergic blocking activity. It binds to and inhibits the dopamine D2 receptor in the CNS, effectively reducing dopaminergic neurotransmission.

Pharmacodynamics

Pimozide is an orally active antipsychotic that blocks dopaminergic receptors in the CNS. This blockade leads to alterations in central dopamine metabolism and function, contributing to both therapeutic and adverse effects. Pimozide is less likely to cause sedation and hypotension compared to other neuroleptics, due to its specific blocking activity on dopamine receptors.

Pharmacokinetics

Pimozide exhibits a variable half-life and is well absorbed from the gastrointestinal tract. It undergoes hepatic metabolism, primarily by cytochrome P450 enzymes, and is excreted in urine as metabolites. The pharmacokinetics may be influenced by factors such as age, liver function, and co-administration with other drugs.

Contra-indications

  • CNS depression
  • comatose states
  • pheochromocytoma
  • history of arrhythmias
  • family history of congenital QT prolongation

Adverse effects

  • decreased appetite
  • depression
  • fatigue
  • headache
  • hyperhidrosis
  • hypersalivation
  • muscle complaints
  • restlessness
  • sebaceous gland disorders

Interactions

  • antifungals, azoles + pimozide: Severe (increases exposure)
  • pimozide + dopamine receptor agonists: Severe (decreases effects)
  • grapefruit juice + pimozide: Severe (increases exposure)
  • clarithromycin + pimozide: Severe (increases exposure)
  • erythromycin + pimozide: Severe (increases exposure)
  • panobinostat + pimozide: Severe (increases exposure)
  • ribociclib + pimozide: Severe (increases exposure)
  • larotrectinib + pimozide: Moderate (increases exposure)
  • palbociclib + pimozide: Moderate (increases exposure)
  • rucaparib + pimozide: Moderate (increases exposure)

Precautions

  • Hypothyroidism
  • hepatotoxicity risk with phenothiazines
  • risk factors for hypoventilation

Pregnancy

Manufacturer advises use only if potential benefit outweighs risk.

Breast-feeding

Manufacturer advises to avoid for 48 hours after dose (express and discard milk produced during this time) - present in milk in animal studies.

Storage

Store at room temperature, away from moisture and heat.

Formulations

  • Tablets
  • Oral solution
BNF 85 (British National Formulary) p.446 BNF for Children 2019-2020 p.275 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Pimozide

PubChem CID 16362

Molecular formula: C28H29F2N3O

Mechanism of action

The ability of pimozide to suppress motor and phonic tics in Tourette's Disorder is thought to be primarily a function of its dopaminergic blocking activity. Pimozide binds and inhibits the dopamine D2 receptor in the CNS.

Pharmacodynamics

Pimozide is an orally active antipsychotic drug product which shares with other antipsychotics the ability to blockade dopaminergic receptors on neurons in the central nervous system. However, receptor blockade is often accompanied by a series of secondary alterations in central dopamine metabolism and function which may contribute to both pimozide's therapeutic and untoward effects. In addition, pimozide, in common with other antipsychotic drugs, has various effects on other central nervous system receptor systems which are not fully characterized. Pimozide also has less potential for inducing sedation and hypotension as it has more specific dopamine receptor blocking activity than other neuroleptic agents (and is therefore a suitable alternative to haloperidol).

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.